News

During his 2015 State of the Union address, then-President Barack Obama announced what he promised would be an ambitious public health project. “Tonight, I’m launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes...

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva...

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

By Ben Hirschler, Reuters | 11.30.2007
Genetic tests to assess disease risk are proliferating but many are a waste of money and tell people little more...
By Joyce E. Cutler, Bureau of National Affairs | 11.29.2007

California Controller John Chiang (D) Nov. 28 called for an audit of all proceeds of the California Institute for Regenerative...

By Kim Curtis, Assocaited Press | 11.29.2007
A federal appeals court ruled Thursday that collecting DNA evidence from nonviolent drug offenders doesn't violate their privacy rights.

The...
Press Statement
Close up photo of the California Capital Building

The Center for Genetics and Society today called on California Institute for Regenerative Medicine (CIRM) Chair Robert Klein, and Board Member John Reed, to step down following their admitted actions that appear to violate conflict-of-interest laws.

"This is a case of improper and potentially illegal efforts by a CIRM board member, following advice from CIRM Chair Robert Klein, to influence the allocation of public funds," said CGS policy analyst Jesse Reynolds. "But the big picture is the structure of the board - which is required by Proposition 71 to include a majority of members who represent the very institutions waiting in line to receive grants."

The California Institute for Regenerative Medicine (CIRM) is the state agency created by Proposition 71 in 2004 to allocate $3 billion that voters agreed to invest in stem cell research.

Reed has admitted that he lobbied CIRM staff in an attempt to reverse a decision rejecting a grant proposal by a scientist at the Burnham Institute of Medical Research, where he is president.

CIRM Board Chair Robert Klein advised Reed to write the letter. Klein was the primary author of Proposition 71, which explicitly prohibits just this sort of lobbying - though it specifies no remedies for violations.

"This is part of a distinct pattern by Klein," Reynolds said in an op-ed published in today's San Francisco Chronicle. "He repeatedly chooses heavy-handed tactics and misleading statements over transparency and accountability. He routinely dismisses public process, and seems reluctant to assume the ethical obligations of a public official."

"For the recent back-door lobbying, and for other ethical breaches, it's time for Klein to step down," Reynolds added.

On Tuesday, State Controller John Chiang announced that he will lead an audit of the stem cell institute and its conflict-of-interest standards.

The Center supports embryonic stem cell research but opposed the 2004 ballot initiative that established CIRM. It has documented conflicts of interest on the CIRM governing board, reported [PDF] a range of problems at CIRM during its first years, and in January 2006 called on Klein to resign.

The Sacramento Bee's editorial page and the Foundation for Taxpayer & Consumer Rights have also called for Klein's resignation.

The Center for Genetics and Society is a nonprofit information and public affairs organization working to encourage responsible uses and effective societal governance of the new human genetic and reproductive technologies.


Contact:
Jesse Reynolds
510-625-0819 x308


 

By Jesse Reynolds, San Francisco Chronicle | 11.29.2007

Last week was a busy one for stem cell research. But amid the coverage of major technical advances, an all-too-predictable...

By Annalee Newitz, AlterNet | 11.29.2007

A company called 23andme.com launched last week and got wads of media attention for being the first user-friendly Web site...

By Osagie K. Obasogie, Genetic Crossroads | 11.29.2007

Rarely have science, politics, and international diplomacy converged as intensely as they have over the past few days.

Researchers at...

By Terri Somers, San Diego Union Tribune | 11.28.2007
State Controller John Chiang yesterday directed his office to audit the state stem cell institute to ensure that all necessary...